CVE-2026-21980

216.73.216.197

· Published 20/01/2026 22:16 · Modified 20/01/2026 22:16

Labels: CVE-2026-21980 2026-01-20 CVE-2026-21980 [email protected]

Essential information

Published: 20/01/2026 22:16
Modified: 20/01/2026 22:16
Author: —
Creator: —
CVSS: 6.5 MEDIUM (v3.1)
CISA KEV: No
CWE: —
CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

CVSS metrics

Description

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

NVD status

Status: Received — CVE has been recently published to the CVE List and has been received by the NVD.
Source: [email protected]
NVD: View on NVD

Affected products (CPE)

Product	CPE
oracle / life sciences central coding	`cpe:2.3:a:oracle:life_sciences_central_coding:7.0.1.0:::::::*`